Complete Digestive
Natural health product licensed in Canada
- Licence holder
- Grand Health Inc
- NPN or DIN-HM
- 80081215
- Status
- Active licence
- Licence date
- 14 November 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus niger - En entier | 8,500 FCC DP | Not calculated |
| Papaïne Source : Carica papaya - fruit | 50,000 FCC PU | Not calculated |
| Diastase du malt Source : Hordeum vulgare - graine | 150 Unités de degrés de pouvoir diastatique du FCC | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 700 Unités de lipase FIP | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 300 FCC CU | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 2,400 Gelatin digesting units per gram | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 50 FCC GalU | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 300 FCC ALU | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 30,000 FCC HUT | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 3 FCC SAPU | Not calculated |
| alpha-L-arabinofuranoside arabinofuranohydrolase Source : Aspergillus niger - En entier | 200 FCC HCU | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 17 Unité de glucoamylase du FCC | Not calculated |
| bêta-D-fructofuranoside fructohydrolase Source : Saccharomyces cerevisiae - en entier | 150 FCC SU | Not calculated |
| (1-4)-alpha-D-galacturonan glycanohydrolase Source : Aspergillus niger - En entier | 50 Endo-PGU | Not calculated |
| mono ester phosphorique phosphohydrolase Source : Aspergillus niger - En entier | 5 FCC FTU | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Trichoderma longibrachiatum - En entier | 200 Unités d'activité du xylanase | Not calculated |
Non-medicinal ingredients
Maltodextrine, Hydroxypropylméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Digestive Enzymes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use. Nausea, vomiting, and diarrhoea have been known to occur, in which case discontinue use (and consult a health care practitioner). Headaches, heartburn, bloating and hypersensitivity (e.g. allergy) have been known to occur; in which case, discontinue use.
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you have diabetes, consult a health care practitioner prior to use. If you have a gastrointestinal lesion/ ulcer, are taking an anticoagulant/ blood thinner, anti-inflammatory or antibiotic, or are having surgery, consult a health care practitioner prior to use .
Source
Official Health Canada record, licence 80081215
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.